Andalusian Agency for Health Technology Assessment (AETSA) published new recommendations for hip arthroplasty in patients with osteoarthritis

30

May 2017

AETSA aimed to establish recommendations for clinical practice on hip arthroplasty in patients with osteoarthritis through a systematic appraisal of evidence.

The following recommendations were made:

  • In patients with clinical and radiologic criteria of hip osteoarthritis and who have exhausted all possibilities to control this disease with proper medical treatment conservative, hip surgery will be proposed (based on consensus Group)
  • In patients with advances stages of hip osteoarthritis is proposed as therapeutic option the total hip arthroplasty when the expected revision rate at 10 years is less than or equal to 5 % (based on the recommendations from National Institute for Health and Care Excellence)
  • To reduce the risk of complications after hip arthroplasty the use of given bearing surfaces must be based on clinical and functional needs of each patients, regardless age and gender (weak strength of recommendation)
  • The use of ceramic-ceramic bearing surfaces against metal-polyethylene to reduce osteolisys risk after hip arthroplasty at 10 years is suggested (weak strength of recommendation)
  • To reduce the ostheolisys risk in hip osteoarthritis is propose that this intervention was performed in patients with a BMI ≤ 30 kg/m2 (weak strength of recommendation)

The full document in Spanish is available here.

Subscribe to our biweekly newsletter not to miss important reimbursement information.

The latest related news

24

Nov 2022

In November 2022, NHS Digital published a final summary of core changes from OPCS-4.9 to OPCS-4.10 to be introduced from April 01, 2023. OPCS-4 is a statistical classification for clinical coding of interventions and procedures undertaken within the NHS. It is updated every three years. A total of 236 new four-character codes will be implemented in OPCS-4.10. Key changes concern cardiovascular, gastrointestinal, endoscopy, ENT, nephrology and urology, neurology and neurosurgery, obstetrics and gynecology, orthopedic, and breast surgery fields.

Read more

23

Nov 2022

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 21738 of November 4, 2022, Tuscany Regional Healthcare has published assessments of three medical devices in the orthopedics, surgical procedures, and peripheral vascular areas.

Read more

22

Nov 2022

On October 27, 2022, the BfArM (Federal Institute for Drugs and Medical Devices) published the final version of the 2023 OPS procedure coding classification. The OPS, together with the ICD-10-GM (International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification), forms the basis for the reimbursement systems in outpatient and inpatient care in Germany.

Read more

16

Nov 2022

On October 28, 2022, several Resolutions of the General Directorate of the Common Package of Benefits of the National Health and Pharmacy System were published concerning the use of the system for percutaneous repair of the mitral valve with clip, prioritization of patients with type 2 diabetes mellitus for the provision of glucose monitoring systems, and the use of glucose monitoring system with sensors (flash type) for type 1 diabetes mellitus in childhood and adolescence.

Read more

10

Nov 2022

The French National Authority for Health released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies in October 2022. Fourteen recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services. Opinions concern cardiovascular, neurovascular, orthopedic, and ENT devices, as well as medical aids.

Read more